Factors Associated with 60-Day Readmission Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy

Introduction Readmission rates following surgery are subject to scrutiny in efforts to control health care costs. This study was designed to define the 60-day readmission rate following cytoreduction and HIPEC at a high-volume center and to identify factors associated with readmission. Methods Patie...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Annals of surgical oncology Ročník 25; číslo 1; s. 91 - 97
Hlavní autori:	Kelly, Kaitlyn J., Cajas, Luis, Baumgartner, Joel M., Lowy, Andrew M.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Cham Springer International Publishing 01.01.2018 Springer Nature B.V
Predmet:	Adult Aged Antineoplastic Agents - administration & dosage Carcinoma - secondary Carcinoma - therapy Chemotherapy Comorbidity Cytoreduction Surgical Procedures - adverse effects Dehydration Dehydration - etiology Female Gastrointestinal Oncology Humans Hyperthermia, Induced - adverse effects Ileus - etiology Infection - etiology Length of Stay Male Medicine Medicine & Public Health Middle Aged Morbidity Oncology Ostomy - adverse effects Patient admissions Patient Readmission - statistics & numerical data Peritoneal Neoplasms - secondary Peritoneal Neoplasms - therapy Postoperative Complications - etiology Pulmonary Embolism - etiology Retrospective Studies Risk Factors Risk groups Surgery Surgical Oncology Venous Thrombosis - etiology Young Adult Cytoreductive Surgery And Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) Control Health Care Costs Deep Space Infection Stoma Creation Peritoneal Carcinomatosis Index (PCI)
ISSN:	1068-9265, 1534-4681, 1534-4681
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!